Development of a peptide targeting dopamine transporter to improve ADHD-like deficits
Attention-deficit hyperactivity disorder (ADHD) is a neurocognitive disorder characterized by hyperactivity, inattention, working memory deficits and impulsivity. Its worldwide prevalence is estimated to be 3-5% in children and adolescents. The mainstay treatment for ADHD is stimulant medications (e...
Saved in:
Published in | Molecular brain Vol. 11; no. 1; p. 66 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
09.11.2018
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!